Iron therapy in hemodialysis patients: how and when?
Crepaldi
Carlo
C
Nephrology Department, St. Bortolo Hospital, Vicenza, Italy. crepaldi@goldnet.it
Bordoni
Valeria
V
Carta
Maria Rosa
MR
D000284:Administration, Oral; D000818:Animals; D015415:Biomarkers / Q000097:blood; D006454:Hemoglobins / Q000096:biosynthesis; D006801:Humans; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007501:Iron / Q000627:therapeutic use*; D000090463:Iron Deficiencies; D019190:Iron Overload / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D012156:Reticulocytes / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism
D015415:Biomarkers; D006454:Hemoglobins; D014168:Transferrin; D007501:Iron